Products for Research Use Only
RegisterLogin

Cirevetmab

CAT: 0804-HY-P99606-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99606-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Cirevetmab (ZTS-00521426) is an immunoglobulin G2-kappa, Canis lupus familiaris TGFB1 caninized monoclonal antibody. Cirevetmab is an immunomodulator[1].
CAS Number
2473240-98-9
Product Name Alternative
ZTS-00521426
UNSPSC
12352203
Target
TGF-beta/Smad
Type
Inhibitory Antibodies
Related Pathways
Stem Cell/Wnt; TGF-beta/Smad
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cirevetmab.html
Solubility
H2O
Smiles
[Cirevetmab]
References & Citations
[1]International Nonproprietary Names for Pharmaceutical Substances (INN) . WHO Drug Information, Vol. 35, No. 4, 2021.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Alternative Products

CatalogName
T77000Cirevetmab
GTR18337770Cirevetmab Antibody
WA2606Research Grade Cirevetmab
E55B0980Cirevetmab (Reference antibody)
ICH5440-1mgCirevetmab Biosimilar - Research Grade
GTR18696648-01Cirevetmab Canine Monoclonal Antibody
GTR18780485-01(Cirevetmab) Biosimilar Reference Antibody
A136154Cirevetmab Biosimilar (Monoclonal, IgG2, kappa)
RA0723-01Cirevetmab (Biosimilar Reference Antibody) (TGFB1 (Canine) )
PX-TA1826-01Cirevetmab Biosimilar - Anti-TGFB1 (Canine) mAb - Research Grade

Popular Products